Close

Merck (MRK), Adimab Enter Technology Agreement

January 12, 2016 8:09 AM EST Send to a Friend
Adimab, LLC, the global leader in the discovery and optimization of fully human monoclonal and bispecific antibodies, announced that it ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login